Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ')

Abstract

Complementary and integrative healthcare (CIH) is increasingly recognized as a valuable approach to empowering and activating cancer patients. Studies have shown that higher patient activation is positively associated with improved health outcomes and reduced healthcare costs. The CCC-Integrativ study aimed to assess the implementation of an evidence-based counseling service on CIH at four Comprehensive Cancer Centers (CCC) in Germany. In this controlled implementation study, the patient-level intervention included three CIH consultations within a 3-month period delivered by interprofessional teams of physicians and nurses. The primary endpoint was patient activation using the PAM-13 at baseline (T1) and post-intervention (T2), and compared between control (CO, receiving routine care) and the intervention group (IG) using an analysis of covariance. Missing data were handled with multiple imputations. Maintenance effects at 6-month follow-up (T3) were investigated using a linear mixed model. A total of n = 1128 oncology patients (CO = 443, IG = 685) with diverse tumor entities and cancer stages were included in the study. The overall mean baseline PAM-13 score was 69.74 (SD = 14.24) (n = 959 (85.0%)). A statistically significant between-group difference in post-intervention PAM-13 scores was observed (F_group(1, 1866.82) = 8.634, P = 0.003), with an adjusted mean difference of 2.22 PAM-points. Age, gender, tumor entity, disease stage, or CCC study site did not significantly predict post-treatment PAM-13 scores. The maintenance effect of the intervention was not statistically significant (F_timeXgroup(1, 3316.04) = 2.337, P = 0.096). Individually tailored counseling on CIH, offered by specifically trained, interprofessional teams, significantly improved patient activation. Given the established positive effects of higher patient activation, the implementation of such a program at cancer centers may yield beneficial outcomes for both patients and the healthcare system.

Keywords

adult oncology / complementary medicine / complementary and integrative healthcare / herbal medicine / nutritional support / oncology / preventive medicine / patient activation / interprofessional counseling

References

[1] Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 2012; 11(3): 187–203

[2] Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007; 7(1): 4

[3] Academic Consortium for Integrative Medicine & Health. Definition of Integrative Medicine and Health. 2018. Available at the website of imconsortium.org

[4] (NCCIH) NCfCaIH. Complementary, Alternative, or Integrative Health: What’s In a Name? 2018. Available at the website of nccih. nih. gov

[5] Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 2017; 67(3): 194–232

[6] Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD. Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial. JAMA 2018; 320(2): 167–176

[7] Hilfiker R, Meichtry A, Eicher M, Nilsson Balfe L, Knols RH, Verra ML, Taeymans J. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med 2018; 52(10): 651–658

[8] Wayne PM, Lee MS, Novakowski J, Osypiuk K, Ligibel J, Carlson LE, Song R. Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis. J Cancer Surviv 2018; 12(2): 256–267

[9] Haller H, Winkler MM, Klose P, Dobos G, Kümmel S, Cramer H. Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta Oncol 2017; 56(12): 1665–1676

[10] Liu R, Chang A, Reddy S, Hecht FM, Chao MT. Improving patient-centered care: a cross-sectional survey of prior use and interest in complementary and integrative health approaches among hospitalized oncology patients. J Altern Complement Med 2016; 22(2): 160–165

[11] Ben-Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-Sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M. Potential risks associated with traditional herbal medicine use in cancer care: a study of Middle Eastern oncology health care professionals. Cancer 2016; 122(4): 598–610

[12] Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond) 2013; 13(1): 7–12

[13] Leitlinienprogramm Onkologie. (Deutsche Krebsgesellschaft DK, AWMF.) S3-Leitlinie Komplementärmedizin in der Behandlung von onkologischen PatientInnen. 2021. AWMF Registernummer: 32/055OL (Langversion 1.1). Available at the website of leitlinienprogramm-onkologie.de

[14] Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Mansfield S, Mussallem DM, Mustian KM, Price E, Rafte S, Cohen L. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol 2018; 36(25): 2647–2655

[15] Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S; Society for Integrative Oncology. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 2009; 7(3): 85–120

[16] Yeh GY, Chan CW, Wayne PM, Conboy L. The impact of tai chi exercise on self-efficacy, social support, and empowerment in heart failure: insights from a qualitative sub-study from a randomized controlled trial. PLoS One 2016; 11(5): e0154678

[17] Hübner J, Welter S, Ciarlo G, Käsmann L, Ahmadi E, Keinki C. Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients. Med Oncol 2022; 39(12): 192

[18] Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004; 39(4p1): 1005–1026

[19] Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res 2005; 40(6p1): 1918–1930

[20] Alexander JA, Hearld LR, Mittler JN, Harvey J. Patient–physician role relationships and patient activation among individuals with chronic illness. Health Serv Res 2012; 47(3pt1): 1201–1223

[21] Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood) 2013; 32(2): 207–214

[22] Blakemore A, Hann M, Howells K, Panagioti M, Sidaway M, Reeves D, Bower P. Patient activation in older people with long-term conditions and multimorbidity: correlates and change in a cohort study in the United Kingdom. BMC Health Serv Res 2016; 16(1): 582

[23] Regeer H, van Empelen P, Bilo HJG, de Koning EJP, Huisman SD. Change is possible: how increased patient activation is associated with favorable changes in well-being, self-management and health outcomes among people with type 2 diabetes mellitus: a prospective longitudinal study. Patient Educ Couns 2022; 105(4): 821–827

[24] Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors. Health Serv Res 2007; 42(4): 1443–1463

[25] Salyers MP, Matthias MS, Spann CL, Lydick JM, Rollins AL, Frankel RM. The role of patient activation in psychiatric visits. Psychiatr Serv 2009; 60(11): 1535–1539

[26] Cuevas H, Heitkemper E, Huang YC, Jang DE, García AA, Zuñiga JA. A systematic review and meta-analysis of patient activation in people living with chronic conditions. Patient Educ Couns 2021; 104(9): 2200–2212

[27] Paukkonen L, Oikarinen A, Kähkönen O, Kaakinen P. Patient activation for self-management among adult patients with multimorbidity in primary healthcare settings. Health Sci Rep 2022; 5(4): e735

[28] Westman B, Bergkvist K, Karlsson Rosenblad A, Sharp L, Bergenmar M. Patients with low activation level report limited possibilities to participate in cancer care. Health Expect 2022; 25(3): 914–924

[29] Salgado TM, Mackler E, Severson JA, Lindsay J, Batra P, Petersen L, Farris KB. The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices. Support Care Cancer 2017; 25(6): 1797–1807

[30] Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions. J Ambul Care Manage 2007; 30(1): 21–29

[31] Acquati C, Hibbard J, Miller-Sonet E, Zhang A, Ionescu E. The moderating role of informal caregiver’s involvement on the relationship between patient activation and adherence to treatment: Implications for self-management intervention in cancer care. J Clin Oncol 2021; 39(15 suppl): 12083

[32] Janamian T, Greco M, Cosgriff D, Baker L, Dawda P. Activating people to partner in health and self-care: use of the Patient Activation Measure. Med J Aust 2022; 216(Suppl 10): S5–S8

[33] Cronin RM, Dorner TL, Utrankar A, Allen W, Rodeghier M, Kassim AA, Jackson GP, DeBaun MR. Increased patient activation is associated with fewer emergency room visits and hospitalizations for pain in adults with sickle cell disease. Pain Med 2019; 20(8): 1464–1471

[34] Lindsay A, Hibbard JH, Boothroyd DB, Glaseroff A, Asch SM. Patient activation changes as a potential signal for changes in health care costs: cohort study of us high-cost patients. J Gen Intern Med 2018; 33(12): 2106–2112

[35] Hibbard JH, Greene J, Overton V. Patients with lower activation associated with higher costs; delivery systems should know their patients’ ‘scores’. Health Aff (Millwood) 2013; 32(2): 216–222

[36] Greene J, Hibbard JH, Sacks R, Overton V, Parrotta CD. When patient activation levels change, health outcomes and costs change, too. Health Aff (Millwood) 2015; 34(3): 431–437

[37] Valentini J, Fröhlich D, Stolz R, Mahler C, Martus P, Klafke N, Horneber M, Frasch J, Kramer K, Bertz H, Grün B, Tomaschko-Ubeländer K, Joos S. Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC–Integrativ. BMJ Open 2022; 12(2): e055076

[38] Bossert J, Mahler C, Boltenhagen U, Kaltenbach A, Froehlich D, Szecsenyi J, Wensing M, Joos S, Klafke N. Protocol for the process evaluation of a counselling intervention designed to educate cancer patients on complementary and integrative health care and promote interprofessional collaboration in this area (the CCC–Integrativ study). PLoS One 2022; 17(5): e0268091

[39] Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014; 348: g1687

[40] Klafke N, Mahler C, von Hagens C, Uhlmann L, Bentner M, Schneeweiss A, Mueller A, Szecsenyi J, Joos S. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: results from a randomized controlled trial. Cancer Med 2019; 8(8): 3666–3676

[41] Klafke N, Mahler C, von Hagens C, Rochon J, Schneeweiss A, Müller A, Salize HJ, Joos S. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial. Trials 2015; 16(1): 51

[42] Klein GE, Guethlin C. Information and training needs regarding complementary and alternative medicine: a cross-sectional study of cancer care providers in Germany. Integr Cancer Ther 2018; 17(2): 380–387

[43] Blödt S, Mittring N, Schützler L, Fischer F, Holmberg C, Horneber M, Stapf A, Witt CM. A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study. BMC Cancer 2016; 16(1): 843

[44] Horneber M, van Ackeren G, Fischer F, Kappauf H, Birkmann J. Addressing unmet information needs: results of a clinician-led consultation service about complementary and alternative medicine for cancer patients and their relatives. Integr Cancer Ther 2018; 17(4): 1172–1182

[45] Orchard C, Bursey S, Peterson L, Verrilli S. Can workshops provide a way to enhance patient/client centered collaborative teams?: evidence of outcomes from TEAMc online facilitator training and team workshops. Int J Practice-based Learning Health Social Care 2016; 4(2): 73–87

[46] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–381

[47] Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, on behalf of the REDCap Consortium. Building an international community of software platform partners. J Biomed Inform 2019; 95: 103208

[48] Brenk-Franz K, Hibbard JH, Herrmann WJ, Freund T, Szecsenyi J, Djalali S, Steurer-Stey C, Sönnichsen A, Tiesler F, Storch M, Schneider N, Gensichen J. Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patients. PLoS One 2013; 8(9): e74786

[49] Rademakers J, Maindal HT, Steinsbekk A, Gensichen J, Brenk-Franz K, Hendriks M. Patient activation in Europe: an international comparison of psychometric properties and patients’ scores on the short form Patient Activation Measure (PAM-13). BMC Health Services Research 2016; 16(1): 570

[50] Bates JS, Auten J, Sketch MR, Patel T, Clark SM, Morgan KP, Muluneh B, McLaughlin JE, Pinelli NR, Foster MC, Amerine L. Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation. J Oncol Pharm Pract 2019; 25(4): 896–902

[51] Wolever RQ, Webber DM, Meunier JP, Greeson JM, Lausier ER, Gaudet TW. Modifiable disease risk, readiness to change, and psychosocial functioning improve with integrative medicine immersion model. Altern Ther Health Med 2011; 17(4): 38–47

[52] AntolSM. Predictors of patient activation among underserved patients in a nurse-managed health center: a pilot study. University of Maryland, College Park. 2016

[53] John JR, Tannous WK, Jones A. Outcomes of a 12-month patient-centred medical home model in improving patient activation and self-management behaviours among primary care patients presenting with chronic diseases in Sydney, Australia: a before-and-after study. BMC Fam Pract 2020; 21(1): 158

[54] Howell D, Pond GR, Bryant-Lukosius D, Powis M, McGowan PT, Makuwaza T, Kukreti V, Rask S, Hack S, Krzyzanowska MK. Feasibility and effectiveness of self-management education and coaching on patient activation for managing cancer treatment toxicities. J Natl Compr Canc Netw 2023; 21(3): 247–256.e8

[55] Vohra Y, Brown CM, Moczygemba LR, Wilfong L. Evaluating the relationship between patient activation and health-related quality of life (HRQOL) in patients with pancreatic cancer (PwPC). Support Care Cancer 2023; 31(3): 191

[56] Solomon M, Wagner SL, Goes J. Effects of a web-based intervention for adults with chronic conditions on patient activation: online randomized controlled trial. J Med Internet Res 2012; 14(1): e32

[57] Welter S, Keinki C, Ahmadi E, Huebner J. Lay etiology, self-efficacy and patient activation among cancer patients. Cancer Invest 2021; 39(3): 219–228

[58] Harvey L, Fowles JB, Xi M, Terry P. When activation changes, what else changes? the relationship between change in patient activation measure (PAM) and employees’ health status and health behaviors. Patient Educ Couns 2012; 88(2): 338–343

[59] Hibbard JH. Using systematic measurement to target consumer activation strategies. Med Care Res Rev 2009; 66(1 suppl): 9S–27S

[60] Witzig Brändli V, Lange C, Kobleder A, Kohler M. Effectiveness and content components of nursing counselling interventions on self- and symptom management of patients in oncology rehabilitation—a systematic review. Nurs Open 2023; 10(5): 2757–2769

[61] Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease management by tailoring care to the patient’s level of activation. Am J Manag Care 2009; 15(6): 353–360

[62] Bloom DA, Kaplan DJ, Mojica E, Strauss EJ, Gonzalez-Lomas G, Campbell KA, Alaia MJ, Jazrawi LM. The minimal clinically important difference: a review of clinical significance. Am J Sports Med 2023; 51(2): 520–524

[63] Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7(5): 541–546

[64] Wright A, Hannon J, Hegedus EJ, Kavchak AE. Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Manual Manip Ther 2012; 20(3): 160–166

[65] Cook CE. Clinimetrics corner: the minimal clinically important change score (MCID): a necessary pretense. J Manual Manip Ther 2008; 16(4): E82–E83

[66] Kanu C, Brown CM, Rascati K, Moczygemba LR, Mackert M, Wilfong L. Are health literacy and patient activation related to health outcomes in breast cancer patients. Health Lit Res Pract 2021; 5(3): e171–e178

[67] Palumbo R. Examining the impacts of health literacy on healthcare costs. An evidence synthesis. Health Serv Manage Res 2017; 30(4): 197–212

[68] Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 2012; 27(5): 520–526

[69] Krouse RS, Grant M, McCorkle R, Wendel CS, Cobb MD, Tallman NJ, Ercolano E, Sun V, Hibbard JH, Hornbrook MC. A chronic care ostomy self-management program for cancer survivors. Psychooncology 2016; 25(5): 574–581

[70] Lunardi LE, Hill K, Xu Q, Le Leu R, Bennett PN. The effectiveness of patient activation interventions in adults with chronic kidney disease: a systematic review and meta-analysis. 11111 2023; 20(3): 238–258

[71] Frydenberg M, Maindal HT, Fletcher A, Juul L. Is patient activation a mediator of the effect of a health promoting intervention in adults at high risk of type 2 diabetes? A longitudinal path model analysis within a randomised trial. BMC Public Health 2022; 22(1): 439

[72] Lemanska A, Poole K, Manders R, Marshall J, Nazar Z, Noble K, Saxton JM, Turner L, Warner G, Griffin BA, Faithfull S. Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment. Support Care Cancer 2022; 30(1): 347–358

[73] Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Complementary and conventional providers in cancer care: experience of communication with patients and steps to improve communication with other providers. BMC Complement Altern Med 2017; 17(1): 301

[74] Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient–doctor communication of complementary and alternative medicine use: a systematic review. Oncologist 2012; 17(11): 1475–1481

[75] Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA. Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States. JAMA Oncol 2019; 5(5): 735–737

[76] Arslan C, Guler M. Alternative medicine usage among solid tumour patients receiving chemotherapy. Eur J Cancer Care (Engl) 2017; 26(5): e12530

[77] Johnson SB, Park HS, Gross CP, Yu JB. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncol 2018; 4(10): 1375

[78] Hayward RA, Asch SM, Hogan MM, Hofer TP, Kerr EA. Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med 2005; 20(8): 686–691

[79] Wardle JJL, Adams J. Indirect and non-health risks associated with complementary and alternative medicine use: an integrative review. Eur J Integr Med 2014; 6(4): 409–422

RIGHTS & PERMISSIONS

The Author(s). This article is published with open access at link.springer.com and journal.hep.com.cn